NINTEDANIB ESYLATE for Interstitial lung disease: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 21 adverse event reports in the FDA FAERS database where NINTEDANIB ESYLATE was used for Interstitial lung disease.
Most Reported Side Effects for NINTEDANIB ESYLATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 54 | 46.2% | 14 | 16 |
| Nausea | 24 | 20.5% | 6 | 6 |
| Decreased appetite | 20 | 17.1% | 1 | 9 |
| Fatigue | 20 | 17.1% | 5 | 3 |
| Vomiting | 20 | 17.1% | 10 | 2 |
| Dyspnoea | 18 | 15.4% | 5 | 5 |
| Weight decreased | 17 | 14.5% | 6 | 5 |
| Off label use | 16 | 13.7% | 2 | 10 |
| Constipation | 13 | 11.1% | 5 | 2 |
| Dizziness | 13 | 11.1% | 5 | 2 |
| Headache | 13 | 11.1% | 0 | 2 |
| Cough | 12 | 10.3% | 0 | 3 |
| Cerebrovascular accident | 11 | 9.4% | 1 | 9 |
| Chest pain | 11 | 9.4% | 5 | 0 |
| Death | 11 | 9.4% | 11 | 3 |
Other Indications for NINTEDANIB ESYLATE
Idiopathic pulmonary fibrosis (48)
Pulmonary fibrosis (22)
Product used for unknown indication (15)
Lung adenocarcinoma (5)
Other Drugs Used for Interstitial lung disease
NINTEDANIB (2,999)
PIRFENIDONE (1,657)
RITUXIMAB (1,074)
PREDNISOLONE (879)
MYCOPHENOLATE MOFETIL (822)
METHYLPREDNISOLONE (744)
CYCLOPHOSPHAMIDE (623)
TACROLIMUS (565)
PREDNISONE (453)
CYCLOSPORINE (385)